S. Fuehner

Patients with Systemic Juvenile Idiopathic Arthritis (SJIA) Show Differences in Autoantibody Signatures Based on Disease Activity

D. Foell, A. Weinhäusel, K. Vierlinger, 2023, Biomolecules.

Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline

D. Foell, K. Minden, J. Klotsche, 2021, Pediatric Rheumatology.

Impact of IL1RN Variants on Response to Interleukin‐1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis

D. Foell, J. Haas, C. Hinze, 2020, Arthritis & rheumatology.

Calcium and zinc tune autoinflammatory Toll-like receptor 4 signaling by S100A12.

D. Foell, B. Zimmermann, C. Hinze, 2018, The Journal of allergy and clinical immunology.

Prevalence of autoantibodies in patients with juvenile idiopathic arthritis: results from the German inception cohort ICON-JIA

D. Foell, K. Minden, M. Fobker, 2022, Pediatric Rheumatology.

An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial

D. Foell, A. Belot, I. Koné-Paut, 2022, Journal of Clinical Immunology.

Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies

D. Foell, A. Tomelleri, C. Campochiaro, 2024, Journal of clinical immunology.